The contemporary role of blood products and components used in trauma resuscitation

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Volumn 18, Issue 1, 2010, Pages

  Dries, David J ^a,b  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; EMERGENCY HEALTH SERVICE; HEMORRHAGIC SHOCK; HUMAN; INJURY; METHODOLOGY; MILITARY MEDICINE; RESUSCITATION; REVIEW;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; EMERGENCY MEDICAL SERVICES; HUMANS; MILITARY MEDICINE; RESUSCITATION; SHOCK, HEMORRHAGIC; WOUNDS AND INJURIES;

EID: 78549256425     PISSN: None     EISSN: 17577241     Source Type: Journal    
DOI: 10.1186/1757-7241-18-63     Document Type: Review

References (103)

1. Kashuk JL, Moore EE, Sawyer M, Le T, Johnson J, Biffl WL, Cothren CC, Barnett C, Stahel P, Sillman CC, Sauaia A, Banerjee A. Postinjury coagulopathy management: Goal directed resuscitation via POC thrombelastography. Ann Surg 2010, 251:604-614. 10.1097/SLA.0b013e3181d3599c, 20224372.
2. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: A reassessment. J Trauma 1995, 38:185-193. 10.1097/00005373-199502000-00006, 7869433.
3. Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular trauma--a unified approach. J Trauma 1982, 22:672-679. 10.1097/00005373-198208000-00004, 6980992.
4. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma 1997, 42:857-862. 10.1097/00005373-199705000-00016, 9191667.
5. Simmons RL, Collins JA, Heisterkamp CA, Mills DE, Andren R, Phillips LL. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. III Post-resuscitative changes. Ann Surg 1969, 169:455-482. 10.1097/00000658-196904000-00001, 1387454, 5774736.
6. Counts RB, Haisch C, Simon T L, Maxwell NG, Heimbach DM, Carrico CJ. Hemostasis in massively transfused trauma patients. Ann Surg 1979, 190:91-99. 10.1097/00000658-197907000-00020, 1344465, 464685.
7. Ledgerwood AM, Lucas CE. A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile. J Trauma 2003, 54(suppl):S68-S74.
8. Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987, 67:365-368. 10.1111/j.1365-2141.1987.tb02359.x, 3689699.
9. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003, 55:39-44. 10.1097/01.TA.0000075338.21177.EF, 12855879.
10. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ, Gomez GA, Cipolle MD, Rodman GH, Malangoni MA, Hides GA, Omert LA, Gould SA, . PolyHeme Study Group Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: The USA multicenter trial. J Am Coll Surg 2009, 208:1-13. 10.1016/j.jamcollsurg.2008.09.023, 19228496, PolyHeme Study Group.
11. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ, Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: A computer simulation. J Trauma 2003, 54:454-463. 10.1097/01.TA.0000053245.08642.1F, 12634523.
12. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists Practice parameters for the use of fresh-frozen plasma, cryoprecipitate and platelets. JAMA 1994, 271:777-781. 10.1001/jama.271.10.777, 8114215, Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists.
13. Lundsgaard-Hansen P. Treatment of acute blood loss. Vox Sang 1992, 63:241-246. 10.1111/j.1423-0410.1992.tb01228.x, 1481471.
14. Smetannikov Y, Hopkins D. Intraoperative bleeding: A mathematical model for minimizing hemoglobin loss. Transfusion 1996, 36:832-835. 10.1046/j.1537-2995.1996.36996420764.x, 8823461.
15. Milles G, Koucky CJ, Zacheis HG. Experimental uncontrolled arterial hemorrhage. Surgery 1966, 60:434-442.
16. Bickell WH, Bruttig SP, Wade CE. Hemodynamic response to abdominal aortotomy in the anesthetized swine. Circ Shock 1989, 28:321-332.
17. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130. 10.1097/01.TA.0000069184.82147.06, 12813333.
18. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Flaherty SF, Grathwohl KW, Spinella PC, Perkins JG, Beekley AC, McMullin NR, Park MS, Gonzalez EA, Wade CE, Dubick MA, Schwab CW, Moore FA, Champion HR, Hoyt DB, Hess JR. Damage control resuscitation: Directly addressing the early coagulopathy of trauma. J Trauma 2007, 62:307-310. 10.1097/TA.0b013e3180324124, 17297317.
19. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B. The coagulopathy of trauma: A review of mechanisms. J Trauma 2008, 65:748-754. 10.1097/TA.0b013e3181877a9c, 18849786.
20. MacLeod JB. Trauma and coagulopathy. A new paradigm to consider. Arch Surg 2008, 143:797-801. 10.1001/archsurg.143.8.797, 18711042.
21. Martini WZ. Coagulopathy by hypothermia and acidosis: Mechanisms of thrombin generation and fibrinogen availability. J Trauma 2009, 67:202-209. 10.1097/TA.0b013e3181a602a7, 19590336.
22. Duchesne JC, Islam TM, Stuke L, Timmer JR, Barbeau JM, Marr AB, Hunt JP, Dellavolpe JD, Wahl G, Greiffenstein P, Steeb GE, McGinness C, Baker CC, McSwain NE. Hemostatic resuscitation during surgery improves survival in patients with traumatic-induced coagulopathy. J Trauma 2009, 67:33-39. 10.1097/TA.0b013e31819adb8e, 19590305.
23. Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009, 67:125-131.
24. Chesebro BB, Rahn P, Carles M, Esmon CT, Xu J, Brohi K, Frith D, Pittet JF, Cohen MJ. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock 2009, 32:659-665. 10.1097/SHK.0b013e3181a5a632, 19333141.
25. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: Initiated by hypoperfusion: Modulated through the protein C pathway?. Ann Surg 2007, 245:812-818. 10.1097/01.sla.0000256862.79374.31, 1877079, 17457176.
26. Niles SE, McLaughlin DF, Perkins JG, Wade CE, Li Y, Spinella PC, Holcomb JB. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008, 64:1459-1465. 10.1097/TA.0b013e318174e8bc, 18545109.
27. Lau HK. The interaction between platelets and factor VII/VIIa. Transfus Apher Sci 2003, 28:279-283. 10.1016/S1473-0502(03)00047-8, 12725955.
28. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008, 64:1211-1217. 10.1097/TA.0b013e318169cd3c, 18469643.
29. Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg 1996, 131:923-928.
30. Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF. Early coagulopathy after traumatic brain injury: The role of hypoperfusion and the protein C pathway. J Trauma 2007, 63:1254-1262. 10.1097/TA.0b013e318156ee4c, 18212647.
31. Reed RL, Bracey AW, Hudson JD, Miller TA, Fischer RP. Hypothermia and blood coagulation: Dissociation between enzyme activity and clotting factor levels. Circ Shock 1990, 32:141-152.
32. Ganter MT, Cohen MJ, Brohi K, Chesebro BB, Staudenmayer KL, Rahn P, Christiaans SC, Bir ND, Pittet JF. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?. Ann Surg 2008, 247:320-326. 10.1097/SLA.0b013e318162d616, 18216540.
33. Landis RC. Protease activated receptors: Clinical relevance to hemostasis and inflammation. Hematol Oncol Clin North Am 2007, 21:103-113. 10.1016/j.hoc.2006.11.005, 17258121.
34. Ganter MT, Brohi K, Cohen MJ, Shaffer LA, Walsh MC, Stahl GL, Pittet JF. Role of the alternative pathway in the early complement activation following major trauma. Shock 2007, 28:29-34. 10.1097/shk.0b013e3180342439, 17510601.
35. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: An overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006, 60:S3-S11. 10.1097/01.ta.0000199961.02677.19, 16763478.
36. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998, 186:528-533. 10.1016/S1072-7515(98)00082-9, 9583692.
37. Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD. Epidemiology of trauma deaths. Am J Surg 1980, 140:144-150. 10.1016/0002-9610(80)90431-6, 7396078.
38. Teixeira PG, Inaba K, Shulman I, Salim A, Demetriades D, Brown C, Browder T, Green D, Rhee P. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009, 66:693-697. 10.1097/TA.0b013e31817e5c77, 19276739.
39. Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, Cothren CC, Biffl WL, Banerjee A, Sauaia A. Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma:packed red blood cells the answer?. J Trauma 2008, 65:261-271. 10.1097/TA.0b013e31817de3e1, 18695460.
40. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA, St Jacques P, Young PP. Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008, 64:1177-1183. 10.1097/TA.0b013e31816c5c80, 18469638.
41. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
42. Snyder CW, Weinberg JA, McGwin GJ, Melton SM, George RL, Reiff DA, Cross JM, Hubbard-Brown J, Rue LW, Kerby JD. The relationship of blood product ratio to mortality: Survival benefit or survival bias?. J Trauma 2009, 66:358-364. 10.1097/TA.0b013e318196c3ac, 19204508.
43. Riskin DJ, Tsai TC, Riskin L, Hernandez-Boussard T, Purtill M, Maggio PM, Spain DA, Brundage SI. Massive transfusion protocols: The role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009, 209:198-205. 10.1016/j.jamcollsurg.2009.04.016, 19632596.
44. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest 2010, 137:209-220. 10.1378/chest.09-0252, 20051407.
45. Marik PE, Corwin HL. Acute lung injury following blood transfusion: Expanding the definition. Crit Care Med 2008, 36:3080-3084. 10.1097/CCM.0b013e31818c3801, 18824899.
46. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: Prospective nested case-control study. Am R Respir Crit Care Med 2007, 176:886-891.
47. Sihler KC, Napolitano LM. Massive transfusion: New insights. Chest 2009, 136:1654-1667. 10.1378/chest.09-0251, 19995767.
48. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, Hess JR, Dubick MA, Simon CD, Beekley AC, Wolf SE, Wade CE, Holcomb JB. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64:S79-S85. 10.1097/TA.0b013e318160a57b, 18376176.
49. Napolitano L. Cumulative risks of early red blood cell transfusion. J Trauma 2006, 60:S26-S34. 10.1097/01.ta.0000199979.95789.17, 16763477.
50. Schulman CI, Nathe K, Brown M, Cohn SM. Impact of age of transfused blood in the trauma patient. J Trauma 2002, 52:1224-1225. 10.1097/00005373-200206000-00036, 12045660.
51. Makley AT, Goodman MD, Friend LA, Deters JS, Johannigman JA, Dorlac WC, Lentsch AB, Pritts TA. Resuscitation with fresh whole blood ameliorates the inflammatory response after hemorrhagic shock. J Trauma 2010, 68:305-311. 10.1097/TA.0b013e3181cb4472, 20154542.
52. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009, 66:S69-S76. 10.1097/TA.0b013e31819d85fb, 19359973.
53. Dutton RP, Lefering R, Lynn M. Database predictors of transfusion and mortality. J Trauma 2006, 60:S70-S77. 10.1097/01.ta.0000200856.47545.64, 16763484.
54. Inaba K, Teixeira PG, Shulman I, Nelson J, Lee J, Salim A, Brown C, Demetriades D, Rhee P. The impact of uncross-matched blood transfusion on the need for massive transfusion and mortality: Analysis of 5,166 uncross-matched units. J Trauma 2008, 65:1222-1226. 10.1097/TA.0b013e31818e8ff3, 19077605.
55. Committee on Trauma, American College of Surgeons Advanced Trauma Life Support (ATLS). 2008, 55-84. Chicago, 8, Committee on Trauma, American College of Surgeons.
56. Yücel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, Neugebauer EA, Wappler F, Bouillon B, Rixen D, . Polytrauma Study Group of the German Trauma Society Trauma Associated Severe Hemorrhage (TASH) Score: Probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 2006, 60:1228-1237. Polytrauma Study Group of the German Trauma Society.
57. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: Simple as ABC (Assessment of Blood Consumption)?. J Trauma 2009, 66:346-352. 10.1097/TA.0b013e3181961c35, 19204506.
58. Cotton BA, Dossett LA, Haut ER, Shafi S, Nunez TC, Au BK, Zaydfudim V, Johnston M, Arbogast P, Young PP. Multicetner validation of a simplified score to predict massive transfusion in trauma. J Trauma 2010, 69(suppl):S33-S39. 10.1097/TA.0b013e3181e42411, 20622617.
59. Nunez TC, Dutton WD, May AK, Holcomb JB, Yound PP, Cotton BA. Emergency department blood transfusion predicts early massive transfusion and early blood component requirement. Transfusion 2010, 50:1914-1920. 10.1111/j.1537-2995.2010.02682.x, 20456707.
60. Al-Ruzzeh S, Navia JL. The "off-label" role of recombinant factor VIIa in surgery: Is the problem deficient evidence or defective concept?. J Am Coll Surg 2009, 209:659-667. 10.1016/j.jamcollsurg.2009.07.018, 19854409.
61. Veldman A, Hoffman M, Ehrenforth S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr Med Chem 2003, 10:797-811. 10.2174/0929867033457728, 12678684.
62. Viles-Gonzalez JF, Anand SX, Zafar MU, Fuster V, Badimon JJ. Tissue factor coagulation pathway: A new therapeutic target in atherothrombosis. J Cardiovasc Pharmacol 2004, 43:669-676. 10.1097/00005344-200405000-00009, 15071354.
63. Levi M, Peters M, Büller HR. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Crit Care Med 2005, 33:883-890. 10.1097/01.CCM.0000159087.85970.38, 15818119.
64. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006, 295:293-298.
65. Meng ZH, Wolberg AS, Monroe DM, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003, 55:886-891. 10.1097/01.TA.0000066184.20808.A5, 14608161.
66. Nishijima DK, Zehtabchi S. Evidence-based Emergency Medicine/Critically Appraised Topic. The efficacy of recombinant activated factor VII in severe trauma. Ann Emerg Med 2009, 54:737-744. 10.1016/j.annemergmed.2009.01.027, 19285753.
67. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y, . for the NovoSeven Trauma Study Group Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-18. 10.1097/01.TA.0000171453.37949.B7, 16096533, for the NovoSeven Trauma Study Group.
68. Raobaikady R, Redman J, Ball JA, Maloney G, Grounds RM. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: A double-blind, randomized, placebo-controlled trial. Br J Anaesth 2005, 94:586-591. 10.1093/bja/aei102, 15734783.
69. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B, . CONTROL Study Group Results of the CONTROL trial: Efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010, 69:489-500. 10.1097/TA.0b013e3181edf36e, 20838118, CONTROL Study Group.
70. Wade CE, Eastridge BJ, Jones JA, West SA, Spinella PC, Perkins JG, Dubick MA, Blackbourne LH, Holcomb JB. Use of recombinant factor VIIa in US military casualties for a five-year period. J Trauma 2010, 69:353-359. 10.1097/TA.0b013e3181e49059, 20699744.
71. Dutton RP, McCunn M, Hyder M, D'Angelo M, O'Connor J, Hess JR, Scalea TM. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004, 57:709-719. 10.1097/01.TA.0000140646.66852.AB, 15514523.
72. Stein DM, Dutton RP, Kramer ME, Scalea TM. Reversal of coagulopathy in critically ill patients with traumatic brain injury: Recombinant factor VIIa is more cost-effective than plasma. J Trauma 2009, 66:63-75. 10.1097/TA.0b013e318191bc8a, 19131807.
73. Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: A meta-analysis of randomized control trials. Ann Surg 2008, 248:61-68. 10.1097/SLA.0b013e318176c4ec, 18580208.
74. Hardy JF, Bélisle S, Van der Linden P. Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: A review of 17 randomized controlled trials. Ann Thorac Surg 2008, 86:1038-1048. 10.1016/j.athoracsur.2008.05.013, 18721620.
75. Hess JR. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program 2007, 187-191.
76. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004, 126:11-28.
77. Dickneite G, Doerr B, Kaspereit F. Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate. Anesth Analg 2008, 106:1070-1077. 10.1213/ane.0b013e318165dfbb, 18349175.
78. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009, 102:345-354. 10.1093/bja/aen391, 2642652, 19168856.
79. Dickneite G, Dörr B, Kaspereit F, Tanaka KA. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010, 68:1151-1157. 10.1097/TA.0b013e3181b06364, 19996804.
80. Lawson JM, Murphy MP. Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol 2004, 41:55-64. 10.1053/j.seminhematol.2003.11.012, 14872423.
81. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007, 4:CD001886.
82. Ekbäck G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckström J, Carlsson O, Schött U. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000, 91:1124-1130.
83. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: Introduction. Semin Thromb Hemost 1997, 23:493-501. 10.1055/s-2007-996127, 9469621.
84. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 Trial Collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomized, placebo-controlled trial. Lancet 2010, 376:23-32. 10.1016/S0140-6736(10)60835-5, 20554319, CRASH-2 Trial Collaborators.
85. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007, 5:289-295. 10.1111/j.1538-7836.2007.02319.x, 17109736.
86. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997, 42:716-722. 10.1097/00005373-199704000-00023, 9137263.
87. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001, 12:327-337. 10.1097/00001721-200107000-00001, 11505075.
88. Jeger V, Zimmermann H, Exadaktylos AK. Can rapidTEG accelerate the search for coagulopathies in the patient with multiple injuries?. J Trauma 2009, 66:1253-1257. 10.1097/TA.0b013e31819d3caf, 19359945.
89. Carroll RC, Craft RM, Langdon RJ, Clanton CR, Snider CC, Wellons DD, Dakin PA, Lawson CM, Enderson BL, Kurek SJ. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res 2009, 154:34-39. 10.1016/j.trsl.2009.04.001, 19524872.
90. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, Holcomb JB. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009, 67:266-276. 10.1097/TA.0b013e3181ae6f1c, 19667878.
91. Hartert H. Blutgerinnungstudien mit der Thromboelastographic, einen neven Untersuchungsverfahren. Klin Wochenschr 1948, 26:577-583. 10.1007/BF01697545, 18101974.
92. Stahel PF, Moore EE, Schreier SL, Flierl MA, Kashuk JL. Transfusion strategies in postinjury coagulopathy. Curr Opin Anaesthesiol 2009, 22:289-298. 10.1097/ACO.0b013e32832678ed, 19390256.
93. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008, 65:535-543. 10.1097/TA.0b013e31818379a6, 18784565.
94. Nielson VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007, 18:247-252. 10.1097/MBC.0b013e328092ee05, 17413761.
95. Gaarder C, Naess PA, Frischknecht Christensen E, Hakala P, Handolin L, Heier HE, Ivancev K, Johansson P, Leppäniemi A, Lippert F, Lossius HM, Opdahl H, Pillgram-Larsen J, Røise O, Skaga NO, Søreide E, Stensballe J, Tonnessen E, Töttermann A, Ortenwall P, Ostlund A. Scandinavian Guidelines - "The massively bleeding patient". Scand J Surgery 2008, 97:15-36.
96. Segal JB, Dzik WH, . Transfusion Medicine/Hemostasis Clinical Trials Network Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review. Transfusion 2005, 45:1413-1425. 10.1111/j.1537-2995.2005.00546.x, 16131373, Transfusion Medicine/Hemostasis Clinical Trials Network.
97. Rossaint R, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Gordini G, Stahel PF, Hunt BJ, Neugebauer E, Spahn DR. Key issues in advanced bleeding care in trauma. Shock 2006, 26:322-331. 10.1097/01.shk.0000225403.15722.e9, 16980877.
98. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondejar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR. Management of bleeding following major trauma: An updated European guideline. Crit Care 2010, 14:R52. 10.1186/cc8943, 2887168, 20370902.
99. Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008, 100:792-797. 10.1093/bja/aen083, 18440953.
100. Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: A before and after study. Vox Sang 2009, 96:111-118. 10.1111/j.1423-0410.2008.01130.x, 2667686, 19152603.
101. Simmons JW, White CE, Eastridge BJ, Mace JE, Wade CE, Blackbourne LH. Impact of policy change on US Army combat transfusion practices. J Trauma 2010, 69(Suppl):S75-S80. 10.1097/TA.0b013e3181e44952, 20622624.
102. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: The paradigm of plasma and platelets-a review of the current literature. Transfusion 2010, 50:701-710. 10.1111/j.1537-2995.2009.02458.x, 19929864.
103. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R, . Task Force for Advanced Bleeding Care in Trauma Management of bleeding following major trauma: A European guideline. Crit Care 2007, 11:R17. 10.1186/cc5686, 2151863, 17298665, Task Force for Advanced Bleeding Care in Trauma.